Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

Faculty Opinions recommendation of Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression.
Fernández-Zapico, Martín E.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | May 12, 2014 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.718335485.793494316 Get It

Faculty Opinions recommendation of The human microbiome and surgical disease.
Chua, Heidi K, Chu, Daniel I.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | May 12, 2014 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.718365566.793494527 Get It

Faculty Opinions recommendation of Transcranial amelioration of inflammation and cell death after brain injury.
Eyo, Ukpong B , Wu, Long‐Jun , Eyo, Ukpong B.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | May 12, 2014 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.718201301.793494630 Get It

Tibiofemoral alignment in posterior stabilized total knee arthroplasty: Static alignment does not predict dynamic tibial plateau loading
Miller, Emily J. , Pagnano, Mark W. , Kaufman, Kenton R. , Kaufman, Kenton R

Journal of Orthopaedic Research | May 12, 2014 | Volume: 32 | Issue: 8 | Pages: 1068-1074

10.1002/jor.22644 | PMID 24820681 Get It

ABSTRACTFor total knee arthroplasty (TKA), neutral mechanical alignment produces balanced static knee loading. Dynamically, knee loading is affected by more than limb static alignment. We compared static and dynamic knee loading following TKA. Fifteen TKA patients were evaluated pre‐operatively and 2 months and 2 years post‐operatively. Tibiofemoral angles and medial tibial plateau loading were calculated. Pre‐operatively, static medial load was greater for varus than valgus knees. Post‐operatively, no relationship existed between tibiofemoral angle and static medial plateau load. Pre‐operatively and post‐operatively, dynamic medial load was not dependent on tibiofemoral angle. While all patients achieved equal static plateau load distributions at 2 years, only 47% had dynamic medial load distributions of 50 ± 10%. Static tibiofemoral alignment alone does not predict dynamic tibial loading. © 2014 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 32:???–???, 2014.
Time Trends in Glucocorticoid Use in Rheumatoid Arthritis: Results From a Population‐Based Inception Cohort, 1980–1994 Versus 1995–2007
Makol, Ashima , Davis, John M. , Crowson, Cynthia S. , Therneau, Terry M. , Gabriel, Sherine E., Matteson, Eric L. , Davis, John M , Makol, Ashima

Arthritis Care & Research | May 12, 2014 | Volume: 66 | Issue: 10 | Pages: 1482-1488

10.1002/acr.22365 | PMID 24821680 Get It

ObjectiveTo examine trends in glucocorticoid (GC) use and dosing among patients diagnosed with rheumatoid arthritis (RA) over time.MethodsA population‐based inception cohort of RA patients diagnosed during 1980–2007 was followed longitudinally through their medical records until death, migration, or December 31, 2008. GC start and stop dates were collected, along with doses in prednisone equivalents.ResultsThe study population comprised 349 patients (68% women) diagnosed in 1980–1994 and 464 (69% women) diagnosed in 1995–2007, with a median followup of 15.3 and 5.7 years, respectively. A higher proportion of patients started GCs in their first year of disease in 1995–2007 (68% versus 36%; P < 0.001), but the starting dose (mean 8.7 versus 10.3 mg; P = 0.08) and cumulative dose in the first year of use (mean 1.8g [mean daily dose 4.9 mg] versus 2.1 gm [mean daily dose 5.8 mg]; P = 0.48) were not different. A higher proportion also discontinued GCs in their first year of disease in the 1995–2007 cohort (P < 0.001). These differences in GC initiation and discontinuation persisted throughout followup. Prevalence of GC use was higher in the 1995–2007 cohort for the first 3 years of disease.ConclusionMore patients are starting GCs early in their disease course now compared to previously, which is consistent with established treatment guidelines. A higher proportion are also discontinuing GCs, but the proportion of patients taking GCs at any given point of disease during the first 4 years is higher now than previously. Despite early addition of a disease‐modifying antirheumatic drug, some patients may not be able to discontinue GCs over the long term.
Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives
Alonso‐Coello, Pablo , Montori, Víctor M. , Díaz, Mireya , Dalmau, Gemma Mas , Díez, A.I. Fernández, Solà, Iván , Roura, Mercè, Souto, Juan Carlos , Oliver, Sven, Ruíz, Rafael Azuar , Coll‐Vinent, Blanca , Gich, Ignasi , Schünemann, Holger J. , Devereaux, P.J. , Guyatt, Gordon , Montori, Victor M , Schünemann, Holger J , Carlos Souto, Juan , Alonso-Coello, Pablo

Health Expectations | May 12, 2014 | Volume: 18 | Issue: 6 | Pages: 2318-2327

10.1111/hex.12201 | PMID 24813058 Get It

AbstractBackgroundExploration of values and preferences in the context of anticoagulation therapy for atrial fibrillation (AF) remains limited. To better characterize the distribution of patient and physician values and preferences relevant to decisions regarding anticoagulation in patients with AF, we conducted interviews with patients at risk of developing AF and physicians who manage patients with AF.MethodsWe interviewed 96 outpatients and 96 physicians in a multicenter study and elicited the maximal increased risk of bleeding (threshold risk) that respondents would tolerate with warfarin vs. aspirin to achieve a reduction in three strokes in 100 patients over a 2‐year period. We used the probabilistic version of the threshold technique.ResultsThe median threshold risk for both patients and physicians was 10 additional bleeds (10 P = 0.7). In both groups, we observed large variability in the threshold number of bleeds, with wider variability in patients than clinicians [patient range: 0–100, physician range: 0–50]. We observed one cluster of patients and physicians who would tolerate <10 bleeds and another cluster of patients, but not physicians, who would accept more than 35.ConclusionsOur findings suggest wide variability in patient and physician values and preferences regarding the trade‐off between strokes and bleeds. Results suggest that in individual decision making, physician and patient values and preferences will often be discordant; this mandates tailoring treatment to the individual patient's preferences.
A case–control study of childhood trauma in the development of irritable bowel syndrome
Halland, Magnus , Almazar, Ann E., Lee, R., Atkinson, Elizabeth J. , Larson, Joseph J. , Talley, Nicholas J., Saito, Y. A., Saito, Y. A.

Neurogastroenterology & Motility | May 12, 2014 | Volume: 26 | Issue: 7 | Pages: 990-998

10.1111/nmo.12353 | PMID 24813232 Get It

AbstractBackgroundThe etiology of irritable bowel syndrome (IBS) is not been fully elucidated, but childhood trauma may disturb the brain–gut axis and therefore be important. Thus, we conducted a family based case–control study of IBS cases and their relatives with the aims to (i) determine the frequency of childhood trauma among IBS cases and controls as well as their relatives, and (ii) assess childhood trauma among IBS cases with affected relatives (familial IBS).MethodsOutpatients with IBS, matched controls, and their first‐degree relatives completed a self‐report version of Bremner' Early Trauma Inventory. Percent of cases and controls with a family history were compared and odds ratios were computed using chi‐squared test; recurrence risks to relatives were computed using logistic regression and generalized estimating equations.Key ResultsData were collected from 409 cases, 415 controls, 825 case relatives, and 921 control relatives. IBS cases had a median age of 50 and 83% were women. Of IBS cases, 74% had experienced any general trauma compared to 59% among controls, yielding an odds ratio of 1.56 (95% CI: 1.13–2.15, p < 0.008). There were no statistical differences between IBS relatives and control relatives with regards to lifetime trauma.Conclusions & InferencesIBS is associated with childhood trauma, and these traumas often occur prior to onset of IBS symptoms. This provides further insight into how traumatic childhood events are associated with development of adult IBS.
Levorphanol: Revisiting an Underutilized Analgesic
Prommer, Eric

Palliative Care: Research and Treatment | May 11, 2014 | Volume: 8 | Issue: No issue available | Pages: No page available

10.4137/pcrt.s13489 | PMID 25278763 Get It

Levorphanol (levo-3-hydroxy- N-methylmorphinan) is a step 3 opioid first developed in the 1940s as an alternative to morphine. Levorphanol belongs to the morphinan opioid series. Levorphanol has greater potency than morphine and is a potent N-methyl-D aspartate (NMDA) antagonist. Levorphanol interferes with the uptake of norepinephrine and serotonin, which makes it potentially useful for neuropathic pain. Glucuronidation changes Levorphanol to Levorphanol-3-glucuronide with excretion by the kidney. Levorphanol has a long half-life and may accumulate with repeated dosing. Levorphanol can be administered orally, intravenously, and subcutaneously. This article provides an update regarding the pharmacodynamics, pharmacology, and clinical efficacy of this often overlooked step 3 opioid.
Functional outcomes and quality of life following surgical treatment of aneurysmal bone cysts of the pelvis in children
Novais, Eduardo N. , Zimmerman, Amy K., Lewallen, Laura, Rose, Peter S. , Sim, Franklin H. , McIntosh, Amy L.

Journal of Children's Orthopaedics | May 10, 2014 | Volume: 8 | Issue: 3 | Pages: 281-288

10.1007/s11832-014-0588-x | PMID 24817630 Get It

Background Aneurysmal bone cysts (ABCs) are a benign aggressive tumor that occurs rarely in the pelvis in the pediatric population. Pelvic ABCs may involve the triradiate cartilage and/or the acetabulum, which increases the technical difficulty of surgical treatment and has potential implications on the growth and development of the hip joint. This study examines the clinical presentation, rate of surgical complications, and recurrence rate, as well as, long-term clinical and functional outcomes of children with pelvic ABCs treated at a single institution by a single treatment modality. Methods Between 1988 and 2008, 142 children with histologically confirmed ABCs were treated at our institution. Seventeen (12 %) tumors were located in the pelvis. A total of 13 pelvic ABCs (5 ilium-periacetabular, 4 pubic, 3 ilium-iliac wing, and 1 ischium) were included in this study. There were eight male and five female patients with a mean age of 12.9 years (range 4.1–17.5 years) at the time of surgery. The Toronto Extremity Salvage Score (TESS), the Musculoskeletal Tumor Society 1993 (MSTS’93) score, and the Short Form Health Survey Sf-36 were obtained at a minimum 5-year follow-up in all patients (mean follow-up 11.5 years, range 5.5–19.8 years). The mean age at follow-up was 24.3 years (range 14.6–32.6 years). Results All patients were treated surgically with intralesional curettage extended with a high-speed burr and bone grafting. Eight patients received adjunctive therapy with phenol. Five patients had preoperative selective arterial embolization. Of the 13 patients, 1 had a local recurrence diagnosed at 6 months after surgery. The only complication in the cohort was a superficial wound infection. At the latest follow-up, all patients were free of disease. The mean TESS score was 95 and the mean MSTS’93 score was 93 %. The mean self-rated general health score, according to the SF-36 was 87 % of total points possible. Conclusions Extended curettage and bone grafting of pelvic ABCs in the pediatric population can yield high clinical and functional scores at an average of 11 years follow-up with a low rate of complications and recurrence. Level of evidence IV, case series.
Microbial Population Dynamics in the Hemolymph of Manduca sexta Infected with Xenorhabdus nematophila and the Entomopathogenic Nematode Steinernema carpocapsae
Reese, Jordan , Casanova‐Torres, Ángel M., Goodrich‐Blair, Heidi , Forst, Steven , Reese, Jordan M, Singh, Swati

Applied and Environmental Microbiology | May 10, 2014 | Volume: 80 | Issue: 14 | Pages: 4277-4285

10.1128/aem.00768-14 | PMID 24814780 Get It

ABSTRACT Xenorhabdus nematophila engages in a mutualistic association with the nematode Steinernema carpocapsae . The nematode invades and traverses the gut of susceptible insects. X. nematophila is released in the insect blood (hemolymph), where it suppresses host immune responses and functions as a pathogen. X. nematophila produces diverse antimicrobials in laboratory cultures. The natural competitors that X. nematophila encounters in the hemolymph and the role of antimicrobials in interspecies competition in the host are poorly understood. We show that gut microbes translocate into the hemolymph when the nematode penetrates the insect intestine. During natural infection, Staphylococcus saprophyticus was initially present and subsequently disappeared from the hemolymph, while Enterococcus faecalis proliferated. S. saprophyticus was sensitive to X. nematophila antibiotics and was eliminated from the hemolymph when coinjected with X. nematophila . In contrast, E. faecalis was relatively resistant to X. nematophila antibiotics. When injected by itself, E. faecalis persisted (∼10 3 CFU/ml), but when coinjected with X. nematophila , it proliferated to ∼10 9 CFU/ml. Injection of E. faecalis into the insect caused the upregulation of an insect antimicrobial peptide, while the transcript levels were suppressed when E. faecalis was coinjected with X. nematophila . Its relative antibiotic resistance together with suppression of the host immune system by X. nematophila may account for the growth of E. faecalis . At higher injected levels (10 6 CFU/insect), E. faecalis could kill insects, suggesting that it may contribute to virulence in an X. nematophila infection. These findings provide new insights into the competitive events that occur early in infection after S. carpocapsae invades the host hemocoel.